The Health Care Commission and Chesapeake Regional Information System for our Patients (CRISP) are hosting the Blueprint for Dispenser Reporting of Non-CDS Dispenses webinar on July 23 at 1:00 pm EST via Zoom. Registration is required by July 21. During the webinar, presenters will discuss new requirements for dispensers to report noncontrolled (non-CDS) prescription drugs to the prescription drug monitoring program (PDMP) starting September 1, outlined in Noncontrolled Prescription Drugs Dispenser Data Submission Manual.  Attendees are encouraged to share questions ahead of the webinar. Please email your questions to mhcc.noncds@maryland.gov. Please note, CRISP will also host a technical webinar on July 29 at 1:00 pm EST via Zoom to walk through the process for submitting non-CDS dispensing information. Please register in advance for the Non-CDS Data Submission Webinar.  

Also in Maryland, NACDS reminds members that Medicaid pays for certain pharmacy healthcare services including MTM, administration of medications, tobacco cessation and vaccinations. They will also pay for any services provided under a collaborative practice agreement (CPA). For more details and enrollment instructions, please refer to this Advisory Bulletin.  

For more information, contact NACDS’ Jill McCormack at 717-592-8977.

Medicaid Fee-for-Service released a bulletin updating its Brand vs Generic Preferred Drug List.  

Also in Maryland, the Prescription Drug Affordability Board's (PDAB's) Stakeholder Council will meet virtually on June 23 at 2:00 pm. The agenda and other meeting materials will be available on the Stakeholder Council page prior to the scheduled meeting. Registration is required to receive the meeting link.  

Finally in Maryland, the Prescription Drug Affordability Board also released an RFI to inform its cost review process for the drugs Skyrizi and Dupixet. Manufacturers, insurers, pharmacy benefit managers and wholesale distributors are eligible to respond.  

For more information, contact NACDS’ Jill McCormack at 717-592-8977.

The Prescription Drug Affordability Board’s (PDAB’s) Stakeholder Council will meet virtually April 28, 2025, at 2:00 pm. The agenda and other meeting materials will be available on the Stakeholder Council page of the PDAB’s website prior to the scheduled meeting. You must register in advance for the meeting link.

For more information, contact NACDS’ Jill McCormack at 717-592-8977.

The Maryland Prescription Drug Affordability Board (PDAB) Stakeholder Council will hold its virtual monthly meeting on Monday, February 24, 2025, at 2pm. The agenda and other meeting materials will be available on the Stakeholder Council page of the PDAB's website prior to the scheduled meeting. Registration is necessary to attend. The PDAB's website has more information about upcoming and previous meetings and related documents and presentation materials. 

Also in Maryland, The Senate Finance Committee will hear SB 438 on Wed. Feb 12. The bill would establish a pharmacy reimbursement rate floor in the Medical Managed Care Program. NACDS is coordinating with members and in-state partners on supportive testimony.

For more information, contact NACDS’ Jill McCormack at 717-592-8977.

The Prescription Drug Affordability Board (PDAB) posted the agenda for the next Stakeholder Council meeting on December 16 at 2:00 pm. You must register for the meeting to receive the log-in information. More information about the Stakeholder Council and the PDAB are available through their webpage.

For more information, contact NACDS’ Jill McCormack at 717-592-8977.

The Prescription Drug Affordability Board (PDAB) is soliciting comments informing the development of draft regulations to implement its plan to determine upper payment limits for drugs of concern. The General Assembly's Legislative Policy Committee approved the plan last week, clearing it to move ahead to the regulatory stage. Comments should be submitted to comments.pdab@maryland.gov by November 8, 2024. 

• Amendments to COMAR 14.01.01.01 (Definitions) 

• New Regulation COMAR 14.01.01.06 (Hearing Procedures) 

• New Chapter – COMAR 14.01.05 (Policy Review, Final Action, Upper Payment Limits)  

• Farxiga, Jardiance, Ozempic and Trulicity (Clinical input on Upper Payment Limits Plan for each drug)

For more information, contact NACDS’ Jill McCormack at 717-592-8977.

COMAR 10.34.42 Pharmacist Prescribing of a Nicotine Replacement Therapy went into effect on October 14. This service is covered by Medicaid for enrolled pharmacies/pharmacists. These regulations are the result of the enactment of SB 62 of 2023 and payment for pharmacy services (Medicaid and commercial plans) as required by HB 1151 of 2023.

For more information, contact NACDS’ Jill McCormack at 717-592-8977.

The Prescription Drug Affordability Board (PDAB) and Stakeholder Council (PDASC) announced upcoming meeting schedules:

• The Prescription Drug Affordability Board Stakeholder Council (PDASC) will meet on November 4 at 2:00 pm. The meeting information page includes a link to register for the virtual meeting. They will not meet on October 21 or 28.
• The Prescription Drug Affordability Board (PDAB) will only have one meeting in October; a virtual Ad-Hoc meeting is scheduled to be held on October 28 at 2:00 pm. The meeting information page includes a link to register and additional information.

For more information, contact NACDS’ Jill McCormack at 717-592-8977.

The Prescription Drug Affordability Board (PDAB) has rescheduled its September 23 Board meeting for September 10. Registration is required to participate. The Board welcomes public comment and input on all its work. Additional information about providing public comment can be found on the Board Meetings page of the PDAB’s website.

For more information, contact NACDS’ Jill McCormack at 717-592-8977.